| Sources | Names Used |
|---|---|
| GDSC1000 | Tivozanib |
| CTRPv2 | tivozanib |
| PharmacoGx | tivozanib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
| Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
| Pubchem: | 9911830 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CISH | CTRPv2 | pan-cancer | AAC | 0.46 | 3e-38 |
| mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.38 | 9e-26 |
| mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-25 |
| mRNA | PDGFRA | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-19 |
| mRNA | RP11-231C18.3 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-18 |
| mRNA | DCUN1D4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |
| mRNA | SLC6A19 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-14 |
| mRNA | ADAT2 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-14 |
| mRNA | ANK1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-13 |
| mRNA | MTO1 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
